Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 6—June 2015

Dose-Response Relationship between Antimicrobial Drugs and Livestock-Associated MRSA in Pig Farming1

Alejandro Dorado-GarcíaComments to Author , Wietske Dohmen, Marian E.H. Bos, Koen M. Verstappen, Manon Houben, Jaap A. Wagenaar, and Dick J.J. Heederik
Author affiliations: Utrecht University, Utrecht, the Netherlands (A. Dorado-García, W. Dohmen, M.E.H. Bos, K.M. Verstappen, J.A. Wagenaar, D.J.J. Heederik); Wageningen UR, Lelystad, the Netherlands (J.A. Wagenaar); PorQ BV, Son, the Netherlands (M. Houben).

Main Article

Table 3

ORs for livestock-associated MRSA in pigs and in humans with increasing use of antimicrobial drugs, the Netherlands, 2011–2013*

     ORs for a 2-fold increase in DDDA/Y
     Pooled pig samples

     Farmers and family members
OR‡ (95% CI)
p value
−2 log RSPL§
OR# (95%CI)
p value
−2 log RSPL§
All farms
1.16 (1.02–1.33)
1.22 (1.01–1.48)
Supply of gilts††
Open 867 1.11 (0.97–1.27) 0.12** 3,828.9 365 1.08 (0.85–1.38) 0.53 1,806.9
0.86 (0.69–1.33)
1.31 (0.94–1.81)
Production type
Farrowing 476 1.38 (1.03–1.86) 0.03** 2,399.2 158 1.28 (0.85–1.94) 0.24 784.3
Farrow-to-finish 954 1.11 (0.95–1.30) 0.18 4,621.4 468 1.19 (0.95–1.50) 0.13 2,439.8

*Farm antimicrobial use was defined as 1 unit increase in the log2 DDDA/Y. Results from the random intercept generalized linear mixed models accounting for the repeated measurements design and adjusting for confounders. DDDA/Y indicates the number of days of antimicrobial use per year for an average animal on the farm. It was determined by dividing the total number of kilograms treatable with a single mass unit of the antimicrobial drug concerned, according to the package insert information, by the average number of animal kilograms on the farm. The denominator comprised sows and fatteners. DDDA/Y, defined daily dosages animal per year; MRSA, methicillin-resistant Staphylococcus aureus; OR, odd ratio; RSPL, residual pseudo-likelihood. Bold type indicates significance (p<0.05).
†Number of observations at all sampling times together (10 pooled pig samples per farm on 36 farms in 4 sampling times). Values are missing for 19 observations.
‡For analysis in pigs, a farm random intercept was included in the mixed models and adjustment of ORs was made for sampling time and age group of pigs in the pool.
§RSPL from the generalized linear mixed models. Models per stratum of external supply or type of production are not nested and -2 log RSPL cannot be used for comparison.
¶Number of observations in all sampling times together (158 persons, 4 sampling times). Values are missing for 6 observations.
#For analysis in humans, a farm and a person random intercept were included in the mixed models, and number of hours worked on the farm and sampling time were used for adjustment of ORs.
**These models additionally showed significant antimicrobial use–time interaction indicating parallel change in antimicrobial use and livestock-associated MRSA prevalence over the study period (see extended explanation in text).
††Farms were defined as open when they received external supplies of gilts ≥1 time per year from at least 1 supplier and as closed when they received no external supply of gilts.

Main Article

1Preliminary results from this study were presented at the 3rd American Society for Microbiology–European Society of Clinical Microbiology and Infectious Diseases (ASM-ESCMID) Conference on Methicillin-resistant Staphylococci in Animals: Veterinary Public Health Implications, 2013 November 4–7, Copenhagen, Denmark (oral presentation, speaker abstract S7:3); and at the Society for Veterinary Epidemiology and Preventive Medicine annual meeting, 2014 March 26–28, Dublin, Ireland (poster presentation).

Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.